This is accompanied by lower production of colonic inflammatory cytokines (i.e., Nlrp3, IL-1β, IL-6, Tnf-α and Ccl2, all these are REV-ERBα target genes) in ZT10-treated than in ZT2-treated colitis mice (Figure 9). The gene discussed is NLRP3; the disease is colitis.